Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
8.25
+0.07 (0.86%)
At close: Dec 20, 2024, 4:00 PM
8.27
+0.02 (0.24%)
After-hours: Dec 20, 2024, 7:53 PM EST
Altimmune Market Cap
Altimmune has a market cap or net worth of $586.78 million as of December 20, 2024. Its market cap has increased by 65.97% in one year.
Market Cap
586.78M
Enterprise Value
449.17M
1-Year Change
65.97%
Ranking
Category
Stock Price
$8.25
Market Cap Chart
Since May 5, 2017, Altimmune's market cap has decreased from $2.19B to $586.78M, a decrease of -73.22%. That is a compound annual growth rate of -15.85%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Omeros | 593.41M |
| Varex Imaging | 590.93M |
| Cross Country Healthcare | 589.87M |
| Mineralys Therapeutics | 588.76M |
| Capricor Therapeutics | 586.56M |
| Simulations Plus | 579.54M |
| GRAIL | 575.92M |
| Fulgent Genetics | 573.50M |